Cosciens Biopharma Inc (CSCIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2011 | 09-2011 | 06-2011 | 03-2011 | 12-2010 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 46,880 | 48,110 | 46,610 | 38,310 | 31,990 |
| Marketable Securities | 0 | 0 | 3,020 | 2,770 | 1,930 |
| Receivables | 7,710 | 4,690 | 4,400 | 4,080 | 4,550 |
| Inventories | 3,450 | 4,180 | 4,880 | 3,870 | 3,310 |
| Other current assets | 2,090 | 1,560 | 1,120 | 1,310 | 2,390 |
| TOTAL | $60,130 | $58,540 | $60,030 | $50,340 | $44,170 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 12,710 | 13,120 | 15,630 | 15,370 | 29,290 |
| TOTAL | $12,710 | $13,120 | $15,630 | $15,370 | $29,290 |
| Total Assets | $75,360 | $74,760 | $79,220 | $68,990 | $76,570 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 50 | 50 | 60 | 60 | 60 |
| Accounts payable and accrued liabilities | 8,060 | 6,840 | 9,330 | 7,860 | 6,380 |
| Accrued Expenses | 3,170 | 2,550 | 3,940 | 3,230 | 2,990 |
| Other current liabilities | 6,330 | 6,120 | 5,690 | 5,500 | 4,040 |
| TOTAL | $17,880 | $15,580 | $19,040 | $16,660 | $13,480 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | 20 | 60 | 60 | 90 |
| Other Non-Current Liabilities | 22,780 | 21,720 | 28,250 | 28,190 | 11,500 |
| TOTAL | $62,020 | $63,230 | $75,470 | $75,850 | $50,640 |
| Total Liabilities | $79,910 | $78,830 | $94,520 | $92,520 | $64,130 |
| Shareholders' Equity | |||||
| Common Shares | 101,880 | 93,860 | 84,790 | 66,010 | 60,140 |
| Retained earnings | -188,960 | -180,110 | -181,190 | -170,620 | -150,750 |
| Other shareholders' equity | 82,540 | 82,190 | 81,110 | 81,090 | 103,040 |
| TOTAL | $-4,540 | $-4,060 | $-15,290 | $-23,520 | $12,430 |
| Total Liabilities And Equity | $75,370 | $74,770 | $79,230 | $69,000 | $76,560 |